Synlogic Announces Board and Executive Changes
Ticker: SYBX · Form: 8-K · Filed: Mar 21, 2024 · CIK: 1527599
| Field | Detail |
|---|---|
| Company | Synlogic, Inc. (SYBX) |
| Form Type | 8-K |
| Filed Date | Mar 21, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001, $40,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
Related Tickers: SYBX
TL;DR
Synlogic's board and exec comp just got a shake-up. New directors in, some execs out.
AI Summary
On March 19, 2024, Synlogic, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for its key executives. These changes are effective as of March 19, 2024.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may affect the company's strategic direction and operational stability.
Key Numbers
- 001-37566 — SEC File Number (Identifies the company's filing history with the SEC.)
- 26-1824804 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Synlogic, Inc. (company) — Registrant
- March 19, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 301 Binney St. Suite 402 (address) — Principal Executive Offices
- Cambridge, Massachusetts (location) — City and State of Principal Executive Offices
- Mirna Therapeutics, Inc. (company) — Former Company Name
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates the departure of 'certain officers' and 'certain directors' but does not specify the exact roles or names in this section of the 8-K.
Who are the newly elected directors?
The filing states that new directors have been elected, but their names and qualifications are not detailed in the provided excerpt.
What are the key changes in compensatory arrangements for officers?
The filing mentions updates to 'Compensatory Arrangements of Certain Officers' but does not provide specific details on the nature or value of these changes in this excerpt.
When were these changes effective?
The changes reported in this 8-K were effective as of March 19, 2024.
What was Synlogic, Inc.'s former company name?
Synlogic, Inc.'s former company name was Mirna Therapeutics, Inc., with a name change date of August 9, 2011.
Filing Stats: 1,160 words · 5 min read · ~4 pages · Grade level 10.5 · Accepted 2024-03-21 17:04:08
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share SYBX The NASDAQ Capital M
- $40,000 — d to receive an annual cash retainer of $40,000 for his service as a non-employee direc
Filing Documents
- sybx-20240319.htm (8-K) — 50KB
- 0000950170-24-034854.txt ( ) — 208KB
- sybx-20240319.xsd (EX-101.SCH) — 55KB
- sybx-20240319_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: March 21, 2024 Synlogic, Inc. By: /s/ Antoine Awad Name: Title: Antoine Awad Principal Executive Officer